Clinical Trial Update: A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer [NA]

View source ↗

Summary

This clinical trial update describes a prospective, single-arm, open-label Phase II study evaluating Ivonescimab (AK112) in combination with TAS-102 for refract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ivonescimab (AK112) (ivonescimab)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Huai'an First People's Hospital | Conditions: MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients | NA | Status: ENROLLING_BY_INVITATION